Sökresultat - "Guerci, Agnès"

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

Sébert, Marie^{Aff1, Aff2, Aff3, IDs41375024021803_cor1}, Freiman, Lucie, Chaffaut, Cendrine, Guerci, Agnès^{Aff3, Aff5}, Peterlin, Pierre^{Aff3, Aff6}, Thépot, Sylvain^{Aff3, Aff7}, Beyne-Rauzy, Odile^{Aff3, Aff8}, Park, Sophie^{Aff3, Aff9}, Cluzeau, Thomas^{Aff3, Aff10}, Chermat, Fatiha, Fenaux, Pierre^{Aff1, Aff2, Aff3}, Preudhomme, Claude, Clappier, Emmanuelle^{Aff1, Aff12}, Chevret, Sylvie, Adès, Lionel^{Aff1, Aff2, Aff3}, Duployez, Nicolas^{Aff1, Aff11, Aff12}, Duchmann, Matthieu^{Aff1, Aff12, IDs41375024021803_cor17}

Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes

Neukirchen-Strapatsas, Judith, Tuechler, Heinz, Porta, Matteo Della, Fenaux, Pierre, Guerci, Agnès, Haas, Rainer, Rossi, Marianna, Sapena, Rosa, Sperr, Wolfgang R., Strupp, Corinna, Stamatoullas, Aspasia, Valent, Peter, Germing, Ulrich, Bennett, John M.

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34⁻ and immature CD34⁺ cells

Berger, Marc G.^{Aff1, Aff2, Aff3, Aff11}, Lebecque, Benjamin^{Aff1, Aff2}, Tassin, Thomas^{Aff1, Aff2}, Dannus, Louis-Thomas^{Aff1, Aff2}, Berger, Juliette^{Aff1, Aff2, Aff3}, Soucal, Mélanie^{Aff1, Aff2}, Guerci, Agnès, Cony-Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Guyotat, Denis, Gagnieu, Marie-Claude, Pereira, Bruno, Saugues, Sandrine^{Aff2, Aff3}, Tournilhac, Olivier^{Aff2, Aff11}, Hermet, Eric, Bourgne, Céline^{Aff1, Aff2}

Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk348) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML)

Bourgne, Céline, Janel, Alexandre, Berger, Juliette, Rapatel, Chantal, Tournilhac, Olivier, Hermet, Eric, Guerci, Agnès, Lioret, Frédérique, Briançon, Aurélie, Bamdad, Mahchid, Boiret-Dupré, Nathalie, Berger, Marc G.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion—The GFM experience

Le Bras, Fabien, Sebert, Marie, Kelaidi, Charikleia, Lamy, Thierry, Dreyfus, François, Delaunay, Jacques, Banos, Anne, Blanc, Michel, Vey, Norbert, Schmidt, Aline, Visanica, Sorin, Eclache, Virginie, Turlure, Pascal, Beyne-Rauzy, Odile, Guerci, Agnès, Delmer, Alain, de Botton, Stéphane, Rea, Delphine, Fenaux, Pierre, Adès, Lionel

Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases

Braun, Thorsten, de Botton, Stéphane, Taksin, Anne-Laure, Park, Sophie, Beyne-Rauzy, Odile, Coiteux, Valérie, Sapena, Rosa, Lazareth, Anne, Leroux, Geneviève, Guenda, Khaled, Cassinat, Bruno, Fontenay, Michaela, Vey, Norbert, Guerci, Agnès, Dreyfus, François, Bordessoule, Dominique, Stamatoullas, Aspasia, Castaigne, Sylvie, Terré, Christine, Eclache, Virginie, Fenaux, Pierre, Adès, Lionel

The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study)

Deau, Bénédicte, Nicolini, Franck E., Guilhot, Joelle, Huguet, Françoise, Guerci, Agnès, Legros, Laurence, Pautas, Cécile, Berthou, Christian, Guyotat, Denis, Cony-Makhoul, Pascale, Gardembas, Martine, Michallet, Mauricette, Hayette, Sandrine, Cayuela, Jean Michel, Weiss, Isabelle Radford, Réa, Delphine, Castaigne, Sylvie, Mahon, François-Xavier, Guilhot, François, Rousselot, Philippe

Pegylated IFN-α2a combined to imatinib mesylate 600 mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600 mg daily alone

Nicolini, Franck E., Hayette, Sandrine, Legros, Laurence, Rousselot, Philippe, Maloisel, Frédéric, Tulliez, Michel, Guerci, Agnès, Charbonnier, Aude, Prébet, Thomas, Rigal-Huguet, Françoise, Chabane, Kaddour, Magaud, Jean-Pierre, Paillet, Carole, Pivot, Christine, Michallet, Mauricette

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

Adès, Lionel, Guerci, Agnes, Raffoux, Emmanuel, Sanz, Miguel, Chevallier, Patrice, Lapusan, Simona, Recher, Christian, Thomas, Xavier, Rayon, Consuelo, Castaigne, Sylvie, Tournilhac, Olivier, de Botton, Stephane, Ifrah, Norbert, Cahn, Jean-Yves, Solary, Eric, Gardin, Claude, Fegeux, Nathalie, Bordessoule, Dominique, Ferrant, Augustin, Meyer-Monard, Sandrine, Vey, Norbert, Dombret, Herve, Degos, Laurent, Chevret, Sylvie, Fenaux, Pierre, for the European APL Group

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

Mahon, François-Xavier, Réa, Delphine, Guilhot, Joëlle, Guilhot, François, Huguet, Françoise, Nicolini, Franck, Legros, Laurence, Charbonnier, Aude, Guerci, Agnès, Varet, Bruno, Etienne, Gabriel, Reiffers, Josy, Rousselot, Philippe

Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: A retrospective analysis on 112 patients

Park, Sophie, Kelaidi, Charikleia, Sapena, Rosa, Vassilieff, Dominique, Beyne-Rauzy, Odile, Coiteux, Valérie, Vey, Norbert, Ravoet, Christophe, Cheze, Stéphane, Rose, Christian, Legros, Laurence, Stamatoullas, Aspasia, Escoffre-Barbe, Martine, Guerci, Agnès, Chaury, Marie-Pierre, Fenaux, Pierre, Dreyfus, François

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

Rose, Christian, Brechignac, Sabine, Vassilief, Dominique, Pascal, Laurent, Stamatoullas, Aspasia, Guerci, Agnes, Larbaa, Dalila, Dreyfus, François, Beyne-Rauzy, Odile, Chaury, Marie Pierre, Roy, Lydie, Cheze, Stephane, Morel, Pierre, Fenaux, Pierre

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results

Adès, Lionel, Sanz, Miguel A., Chevret, Sylvie, Montesinos, Pau, Chevallier, Patrice, Raffoux, Emmanuel, Vellenga, Edo, Guerci, Agnès, Pigneux, Arnaud, Huguet, Francoise, Rayon, Consuelo, Stoppa, Anne Marie, de la Serna, Javier, Cahn, Jean-Yves, Meyer-Monard, Sandrine, Pabst, Thomas, Thomas, Xavier, de Botton, Stéphane, Parody, Ricardo, Bergua, Juan, Lamy, Thierry, Vekhoff, Anne, Negri, Silvia, Ifrah, Norbert, Dombret, Hervé, Ferrant, Augustin, Bron, Dominique, Degos, Laurent, Fenaux, Pierre

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Casadevall, Nicole ^*, Durieux, Pierre, Dubois, Stéphanie, Hemery, François, Lepage, Eric, Quarré, Marie-Catherine, Damaj, Gandhi, Giraudier, Stéphane, Guerci, Agnès, Laurent, Guy, Dombret, Hervé, Chomienne, Christine, Ribrag, Vincent, Stamatoullas, Aspasia, Marie, Jean-Pierre, Vekhoff, Anne, Maloisel, Frédéric, Navarro, Robert, Dreyfus, François, Fenaux, Pierre

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.